Anzeige
Mehr »
Login
Samstag, 05.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Eine goldene Gelegenheit in Kupfer: Warum Gladiator Metals eine Top-Wahl für 2024 sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
352 Leser
Artikel bewerten:
(2)

Chemonics International: Leading International Development Firm, Chemonics, attends Annual United Nations Climate Conference

Chemonics' climate experts will be at the 2022 United Nations Climate Change Conference (COP27) in Sharm El-Sheikh, Egypt this November.

SHARM EL-SHEIKH, Egypt, Nov. 3, 2022 /PRNewswire/ -- Climate change affects every corner of our planet and every development sector, from expanding the range of infectious diseases and driving conflict over limited natural resources to threatening energy supplies and agricultural outputs. As one of the most urgent challenges of our time, climate change requires collaboration and innovation to support countries on their journey towards inclusive, climate-resilient development and net zero carbon emissions economies.


From November 8-10, we will be in Sharm El-Sheikh during COP27 hosting a series of in-person discussions with climate experts and advocates from around the world. "Addressing the global climate crisis is more urgent than ever, and we are proud to be part of COP27 this year to represent the issues - and opportunities for change - in the global development sector," says Anna Slother, Chemonics' executive vice president.

At Chemonics, we leverage our decades of experience in international development and environmental management to support implementation and decision-making based on empirical, science-informed climate information while bolstering the capacity of communities to address climate risks and vulnerabilities and build more resilient livelihoods. "Information about changes in climate and related changes in vulnerability and risk needs to be conveyed to users in a way that they can use it to inform decisions that strengthen rather than threaten their livelihoods," says Chris Perine, managing director of Chemonics' Climate Group. "This is critical to get the buy-in for sustainable adaptation and mitigation strategies that actually work."

Climate change stresses social, economic, and political systems, acting as a multiplier for development challenges and enhancing the likelihood of - and impacts from - conflict. On Tuesday, November 8, 2022, we will focus on Exploring Climate and Fragility in Conflict Prevention, Mitigation, and Recovery with Dr. Ruth Citrin, Executive Director of the Cross-Border Conflict Evidence Policy and Trends (XCEPT) research program funded by UK Aid, Emma Whitaker, Senior Advisor at adelphi, Paul Currie, Associate Director of the Urban Systems Centre at ICLEI Africa, and Brian App, Chemonics' Senior Climate Services Director.

Lack of regulation, comprehensive standards, and equitable stakeholder engagement in nature-based carbon projects has led to pervasive issues for communities and could undermine the credibility of these projects and credits in the voluntary carbon market. On Wednesday, November 9, 2022, join us for a discussion on Enhancing the Quality of Nature-based Carbon Credits with Candace Vinke, Senior Director of Nature-based Innovation at Verra, Dr. Daniel Nepstad, Founder and President of the Earth Innovation Institute, Roberto Gómez, Director of Innovative Conservation Models on the USAID Paramos and Forests Activity, and Maxwell Mcgrath-Horn, Chemonics' Senior Climate Finance Advisor.

Over the last decade, there has been an increase in adaptation programming but only scant evidence of what has - or has not - worked under different contexts. On Thursday, November 10, 2022, we will host our final conversation on Measuring the Effectiveness of Climate Adaptation Interventions with Laurie Ashley, Resilience and Climate Adaptation Advisor at USAID, Emilie Beauchamp, Monitoring, Evaluation, and Learning Lead at the International Institute for Sustainable Development, David Nicholson, Chief Climate Officer at Mercy Corps, and Nik Steinberg, Chemonics' Senior Climate Risk Advisor.

Learn more about our work in climate change and our events at COP27.

About Chemonics International?

Founded in 1975, Chemonics is an international development consulting firm. In more than 70 countries around the globe, our network of 5,000 specialists share a simple belief: that the challenges we face today are best solved through the right partnerships - sharing knowledge, expertise, and experience to deliver results. Where Chemonics works, development works. Follow us on Facebook and Twitter or visit us at www.chemonics.com.

Logo - https://mma.prnewswire.com/media/1040652/Chemonics_International_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/leading-international-development-firm-chemonics-attends-annual-united-nations-climate-conference-301667757.html

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.